Skip to content

CoolCap Followup Study-Coordination of Participating Centers

Long-term Follow-up After Head Cooling for Neonatal Encephalopathy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00581581
Enrollment
62
Registered
2007-12-27
Start date
2007-09-30
Completion date
2009-10-31
Last updated
2013-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Encephalopathy

Keywords

neonatal encephalopathy, therapeutic hypothermia, head cooling, neonatal asphyxia

Brief summary

This observational study will assess long-term functional outcome of survivors from neonatal encephalopathy who were previously treated with either head cooling or with conventional care in a randomized clinical trial. Children's parents will be interviewed by phone by trained staff using the WeeFIM questionnaire to ascertain the childrens' functional performance on a set of skills basic to daily life. This instrument is able to assess a very wide range of abilities, from independently functioning to needing total assistance. The ratings will be used to examine the relationship between the outcome previously measured at 18 months age and functional outcome at school age and to triage the children into those who clearly could not be tested on standardized exams of cognitive functioning, those who potentially could, even if at a low level of cognitive ability, and those who appear to be functioning at an age-appropriate level.

Detailed description

Previous studies have demonstrated that hypothermia for hypoxic-ischemic encephalopathy in the neonatal period is generally safe and feasible, and can improve intermediate term survival without handicap. There is, however, no information on whether cooling improves longer term (school-age) outcomes in non-handicapped survivors. The current observational trial is designed to help obtain additional followup information on children who participated in the initial randomized clinical trial of head-cooling for neonatal encephalopathy. A first step is to collect information on the current status (at 7-8 years of age) of participants in the original study using a standardized telephone questionnaire. This will allow the investigators to more appropriately target children for whom further, more detailed, in-person neurodevelopmental testing would be appropriate. Given limited resources, identification of children for whom such testing would be helpful and instructive is a necessary goal.

Interventions

None listed

Sponsors

Olympic Medical
CollaboratorINDUSTRY
University of Rochester
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to 8 Years
Healthy volunteers
No

Inclusion criteria

* Previous participation in the CoolCap study * Survivors to 7-8 years of age * Parental consent to participation

Exclusion criteria

* Lack of parental consent

Design outcomes

Primary

MeasureTime frameDescription
WeeFIM Score7-8 years after initial interventionWeeFIM instrument (the Functional Independence Measure for Children, Uniform Data System for Medical Rehabilitation, Buffalo, NY) is a set of ratings of 18 skills divided into 3 general domains: 8 Self-care; 5 Mobility; 5 Cognition. Caregivers rate a child about extent of independence, full functioning, in carrying out each of those 18 skills, on a scale from 1 for total assistance, total dependence, maximal prompting, or not testable to 7 for complete independence. The ratings are combined to yield 3 Domain scores and a WeeFIM Total. Favorable=mean+/-2SD. We are reporting the percentage of participants with a favorable response.

Countries

United States

Participant flow

Recruitment details

Individuals who participated in the parent study (CoolCap) were invited to participate in this follow-up study when they were 7-8 years old. Site investigators contacted prior participants' families by phone for consent. Contact information for the families who consented was provided to a central examiner.

Pre-assignment details

Observational study - determination of outcome at 7-8 years after prior randomization in parent study to therapeutic hypothermia vs standard of care for infants with hypoxic-ischemic encephalopathy who met eligibility requirements.

Participants by arm

ArmCount
Therapeutic Hypothermia
Randomized to cooling (original RCT)
32
Standard Care
Randomized to standard care (original RCT)
30
Total62

Baseline characteristics

CharacteristicTherapeutic HypothermiaStandard CareTotal
Age, Categorical
<=18 years
32 Participants30 Participants62 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Age Continuous7.68 years
STANDARD_DEVIATION 0.62
7.66 years
STANDARD_DEVIATION 0.63
7.67 years
STANDARD_DEVIATION 0.62
Region of Enrollment
New Zealand
2 participants2 participants4 participants
Region of Enrollment
United Kingdom
6 participants5 participants11 participants
Region of Enrollment
United States
24 participants23 participants47 participants
Sex: Female, Male
Female
12 Participants18 Participants30 Participants
Sex: Female, Male
Male
20 Participants12 Participants32 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

WeeFIM Score

WeeFIM instrument (the Functional Independence Measure for Children, Uniform Data System for Medical Rehabilitation, Buffalo, NY) is a set of ratings of 18 skills divided into 3 general domains: 8 Self-care; 5 Mobility; 5 Cognition. Caregivers rate a child about extent of independence, full functioning, in carrying out each of those 18 skills, on a scale from 1 for total assistance, total dependence, maximal prompting, or not testable to 7 for complete independence. The ratings are combined to yield 3 Domain scores and a WeeFIM Total. Favorable=mean+/-2SD. We are reporting the percentage of participants with a favorable response.

Time frame: 7-8 years after initial intervention

ArmMeasureValue (NUMBER)
Therapeutic HypothermiaWeeFIM Score78 percentage of participants
Standard CareWeeFIM Score80 percentage of participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026